Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorMarill, Keith A
deSouza, Ian S
Nishijima, Daniel K
Senecal, Emily L
Setnik, Gary S
Stair, Thomas O
Ruskin, Jeremy N
Ellinor, Patrick T
Journal titleAcademic emergency medicine : official journal of the Society for Academic Emergency Medicine
Publication Begin page297
Publication End page306
MetadataShow full item record
AbstractThe objective was to compare the effectiveness of intravenous (IV) procainamide and amiodarone for the termination of spontaneous stable sustained ventricular tachycardia (VT).
A historical cohort study of consecutive adult patients with stable sustained VT treated with IV amiodarone or procainamide was performed at four urban hospitals. Patients were identified for enrollment by admissions for VT and treatment with the study agents in the emergency department (ED) from 1993 to 2008. The primary measured outcome was VT termination within 20 minutes of onset of study medicine infusion. A secondary effectiveness outcome was the ultimate need for electrical therapy to terminate the VT episode. Major adverse effects were tabulated, and blood pressure responses to medication infusions were compared.
There were 97 infusions of amiodarone or procainamide in 90 patients with VT, but the primary outcome was unknown after 14 infusions due to administration of another antidysrhythmic during the 20-minute observation period. The rates of VT termination were 25% (13/53) and 30% (9/30) for amiodarone and procainamide, respectively. The adjusted odds of termination with procainamide compared to amiodarone was 1.2 (95% confidence interval [CI]=0.4 to 3.9). Ultimately, 35/66 amiodarone patients (53%, 95% CI=40 to 65%) and 13/31 procainamide patients (42%, 95% CI=25 to 61%) required electrical therapy for VT termination. Hypotension led to cessation of medicine infusion or immediate direct current cardioversion (DCCV) in 4/66 (6%, 95% CI=2 to 15%) and 6/31 (19%, 95% CI=7 to 37%) patients who received amiodarone and procainamide, respectively.
Procainamide was not more effective than amiodarone for the termination of sustained VT, but the ability to detect a significant difference was limited by the study design and potential confounding. As used in practice, both agents were relatively ineffective and associated with clinically important proportions of patients with decreased blood pressure.
CitationMarill KA, deSouza IS, Nishijima DK, Senecal EL, Setnik GS, Stair TO, Ruskin JN, Ellinor PT. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison. Acad Emerg Med. 2010 Mar;17(3):297-306. doi: 10.1111/j.1553-2712.2010.00680.x. PMID: 20370763.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright (c) 2010 by the Society for Academic Emergency Medicine.
- Amiodarone is poorly effective for the acute termination of ventricular tachycardia.
- Authors: Marill KA, deSouza IS, Nishijima DK, Stair TO, Setnik GS, Ruskin JN
- Issue date: 2006 Mar
- Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
- Authors: Tomlinson DR, Cherian P, Betts TR, Bashir Y
- Issue date: 2008 Jan
- Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest.
- Authors: Markel DT, Gold LS, Allen J, Fahrenbruch CE, Rea TD, Eisenberg MS, Kudenchuk PJ
- Issue date: 2010 Jun
- Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
- Authors: Long B, Koyfman A
- Issue date: 2017 Apr
- Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
- Authors: Samuels LE, Holmes EC, Samuels FL
- Issue date: 2005 Jan